El Salvador vs Madagascar: The number of people with susceptibility test result for rifampicin
El Salvador
26.6
in 2021
Madagascar
15.83
in 2021
El Salvador rank
135th
Madagascar rank
137th
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Madagascar
How they compare
El Salvador currently reports 26.6 against 15.83 in Madagascar, a difference of 10.77.
That makes El Salvador's figure about 1.7 times Madagascar's.
Across all 5 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 135th and Madagascar ranks 137th of 146 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.13 | 0.0111 | 34.12 | El Salvador |
| 2020s | 33.06 | 7.93 | 25.14 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Madagascar?
- El Salvador, at 26.6 against 15.83 in Madagascar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Madagascar?
- 10.77, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Madagascar?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Madagascar rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 135th and Madagascar ranks 137th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.